Cannabis and Biotech Stocks Set to Breakout

HENDERSON, NV / ACCESSWIRE / October 23, 2018 / There are several stocks we see poised to breakout this week. One of the most promising opportunities is Endonovo Therapeutics, Inc. (ENDV). The company's non-invasive pain reduction treatment, SofPulse, could render troublesome opioid prescriptions irrelevant. This 5-cent stock has received price targets from research firms as high as 25 cents a share.

ENDV is sitting at support, so it's a perfect time to do your due diligence before this company makes its next run.

Companies to put on your radar include: Endonovo Therapeutics, Inc. (ENDV), HEXO Corp. (OTC PINK: HYYDF), Roche Holding AG (RHHBY), Puration, Inc. (PURA), and Aleafia Health, Inc. (ALEAF).

Endonovo Therapeutics, Inc. (ENDV)

Market Cap: $15.72M Share Price: $0.042

Endonovo Therapeutics, Inc. (ENDV), a commercial-stage developer of Electroceutical™ Therapies, announced a distribution agreement with Magniant, LLC for the distribution of Sofpulse, its non-invasive Electroceutical™ Therapy for post-operative pain relief and reduction of swelling. The agreement with Magniant includes sales, marketing and distribution targeting the VA, DOD, Indian Health Services, Long Term Care Institutions, Pain Clinics, Wound Clinics and Private Practices among physicians.

Alan Collier, Endonovo Chief Executive Officer, stated, ''We are thrilled to partner with Magniant, an established firm with significant health industry experience, in depth knowledge of product launches and, more importantly, relationships with healthcare professionals and facilities throughout the United States. In addition to a professional, accountable team of commission-based representatives, Magniant delivers meaningful senior leadership in the areas of Supply Chain, FP&A, Operations and Logistics, Marketing, and Clinical Business Development. I welcome the opportunity of working with their team and expanding our Sofpulse device on a national level.''

HEXO Corp. (OTC PINK: HYYDF)

Market Cap: $1.00B Share Price: $5.11

HEXO Corp. was one of 8 companies recently welcomed into the Responsible Cannabis Framework of the Global Cannabis Partnership (GCP). Founded by Revolution Strategy, the Global Cannabis Partnership is a collaboration of leaders in the government-sanctioned, adult-use recreational cannabis industry. With representation from government, private-sector and affiliate organizations, the GCP is creating an international standard for the safe and responsible production, distribution and consumption of legal recreational cannabis.

Roche Holding AG (RHHBY)

Market Cap: $202.17B Share Price: $30.59

Roche's (ROG.S) entrectinib cancer pill was shown to shrink tumours in 57 percent of patients within a group that can only be identified via genetic profiling, as the Swiss drugmaker challenges an alliance of Bayer (BAYGn.DE) and Loxo Oncology (LOXO.O) in a new targeted treatment area.

Puration, Inc. (PURA)

Market Cap: $7.6M Share Price: $0.15

Puration, Inc. announced initiating its first production run of an updated formula for its EVERx CBD Sports Water. This production run will also include the new EVERx labels. The Company introduced its CBD Sports Water at Arnold Schwarzenegger's Arnold Sports Festival early in 2017. Sales of EVERx have since grown 600%.

Aleafia Health, Inc. (ALEAF)

Market Cap: $327.45M Share Price: $2.28

Aleafia Health recently made a significant expansion of its medical clinic business, adding three new clinics, six new physicians and a major expansion of telemedicine services for patients.

Important Disclaimer, Please Read:

The securities, investments, and industries referenced and impacted in the attached content, are risky investments, that can result in significant or entire loss. This article is not advice in making any speculative investment decision.

The attached content may include predictions, estimates or other information that might be considered forward-looking. While such forward-looking statements represent best judgment on what the future holds, at the time of first publishing, they are subject to risks and uncertainties that could cause actual results to differ materially. You are cautioned not to place undue reliance on any forward-looking statements, that may be found in the attached content, as they only reflect as of the date of first publishing. Please keep in mind that authors, producers, disseminators are not obligated to revise or publicly release the results of any revision to any forward-looking statement, that may be found in the attached content, in light of new information or future events.

Regal Consulting LLC is hired by certain companies to increase awareness and disseminate material public information regarding the paying company. ENDV has paid forty-nine thousand dollars and twenty thousand restricted shares for corporate awareness services for the month of October, and continues to pay Regal to disseminate truthful and potentially material information regarding ENDV.

Regal Consulting LLC is not registered with FINRA or any other financial or securities regulatory authority, and does not provide investment advice. The attached content is not investment advice. Regal Consulting LLC is not a broker dealer.

Before making investment decisions, everyone, including viewers of this content, should seek advice and perform deep and thorough research.

Regal Consulting, LLC. may buy or sell additional shares of any company named, referenced, or impacted by information in the attached content, on the open market at any time, including before, during or after the publishing of the content. The amount of stock Regal may own in ENDV can be found updated here: http://www.regalconsultingllc.com/disclaimer/.

Legal Disclaimer

Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. ACR Communication, LLC, which owns Microcapspeculators.com, is not registered with Finra or any other financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. ACR Communication, LLC [and/or] Microcapspeculators.com does not have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice. ACR Communication LLC, which owns Microcapspeculators.com, is compensated for its services in the form of cash-based compensation or in equity in the companies it writes about, or a combination of the two. ACR Communication, LLC has been compensated one thousand dollars cash for this article and seventy-six thousand dollars total by Regal Consulting. LLC, for news commentary articles for ENDV. ENDV and Regal Consulting, LLC were given an opportunity to edit information included in this article. This article is based solely on public information and the opinions of ACR Communication, LLC, which believes the news commentary to include accurate and complete information. We may buy or sell additional shares of ENDV in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information.

For Full Legal Disclaimer Click Here.

Regal Consulting, LLC, For Full Legal Disclaimer Click Here.

Contact Information:

Company Name: Microcap Speculators

Contact Person: Media Manager

Email: info@microcapspecualtors.com

Phone: 1-702-720-6310

Country: United States

Website: http://microcapspeculators.com/

SOURCE: ACR Communication, LLC